UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc

Reference Data

ISIN LU2591956839
Valor Number 125205293
Bloomberg Global ID UBHELUX LX
Fund Name UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich Basel, Switzerland
Phone: +41 61 288 75 01
E-Mail: sh-ubs-funds-feedback@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s)
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least 80% of its assets in equities and other equity interests of companies in developed and emerging markets worldwide that have exposure to sustainable themes which the Portfolio Manager considers to be critical to the trend of healthy living and disease prevention. Those include but are not limited to, healthy lifestyle, healthy nutrition, consumerization of health, disease prevention, mental well-being and longevity. Lifespan increased significantly over the past century, yet the time spent in a healthy state (i.e. health span) still lags behind.
Peculiarities

Fund Prices

Current Price * 11,191.57 USD 14.11.2024
Previous Price * 11,326.71 USD 13.11.2024
52 Week High * 11,776.88 USD 27.09.2024
52 Week Low * 9,420.77 USD 16.11.2023
NAV * 11,191.57 USD 14.11.2024
Issue Price * 11,191.57 USD 14.11.2024
Redemption Price * 11,191.57 USD 14.11.2024
Closing Price *
Indicative Minimum Price
Fund Assets *** 4,628,022
Unit/Share Assets *** 4,300,669
Trading Information SIX

Performance

YTD Performance +9.04% 29.12.2023
14.11.2024
YTD Performance (in CHF) +15.35% 29.12.2023
14.11.2024
1 month -3.95% 14.10.2024
14.11.2024
3 months +0.50% 14.08.2024
14.11.2024
6 months +0.63% 14.05.2024
14.11.2024
1 year +18.40% 14.11.2023
14.11.2024
2 years +12.37% 06.07.2023
14.11.2024
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Koninklijke Philips NV 6.92%
Danone SA 6.19%
Eli Lilly and Co 5.49%
Haleon PLC 5.16%
Mowi ASA 4.01%
Novo Nordisk AS Class B 3.90%
Alcon Inc 3.86%
Shimano Inc 3.51%
Novonesis (Novozymes) B Class B 3.19%
Cava Group Inc 3.01%
Last data update 30.09.2024

Cost / Risk

TER
TER date
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.00%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)